Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
30 results about "Meconopsis horridula" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Meconopsis horridula, the prickly blue poppy, is a flowering plant from the Papaveraceae family. It is an endangered species that grows in high altitudes. The height of the plant varies from 20 cm to 1m. It is a monocarpic, dicot plant.
Traditional Chinese medicine for treating qi-stagnation and blood stasis lumbar disc herniation and preparation method thereof
InactiveCN103520432AQuick effectDefinite curative effectAntipyreticAnalgesicsMedicinal herbsCentipede
The invention provides a traditional Chinese medicine for treating qi-stagnation and blood stasis lumbar disc herniation and a preparation method thereof. The traditional Chinese medicine comprises the following crude drugs: peach kernel, flowers carthami, wine angelica sinensis, ligusticum wallichii, radix clematidis, corydalis tuber, fiveleaf akebia fruit, centipede, lycopodiumfargesii, tall monkshood root, purslane speedwell herb, lycopodium obscurum, meconopsis horridula, grass roots, hypoleuca, aralia undulate, sambucus chinensis, manyspike chloranthus herb, caulis sargentodoxae and yunnan craibiodendron leaf. The traditional Chinese medicine has the beneficial effects that by adopting the traditional Chinese medicine theory in China, the traditional Chinese medicine drug disclosed by the invention is mainly used for promoting blood circulation and removing blood stasis, relaxing veins and dredging collaterals, and circulating vital energy and relieving pain, and treating the qi-stagnation and blood stasis lumbar disc herniation; the traditional Chinese medicine has the advantages of being quick to take effect, accurate in curative effect, high in safety, free of toxic and side effects and not easy to reappear.
Owner:王帅华
Traditional Chinese medicine mosquito repellent
InactiveCN108514543AKill strongStrong driving effectCosmetic preparationsToilet preparationsMedicineTraditional medicine
The invention discloses a traditional Chinese medicine mosquito repellent. The traditional Chinese medicine mosquito repellent is prepared from, by weight, 5-10 parts of marigold, 5-10 parts of wormwood, 3-8 parts of mulberry root, 3-8 parts of tripterygium wilfordii, 10-15 parts of pyrethrum cinerariifolium, 2-7 parts of Chinese gall, 5-15 parts of flos lonicerae, 3-7 parts of meconopsis horridula, 3-7 parts of peach leaf, 3-6 parts of tea tree essential oil and 3-6 parts of lemongrass essential oil. The traditional Chinese medicine mosquito repellent is prepared from eleven plant compositions of the marigold, wormwood, mulberry root, tripterygium wilfordii, pyrethrum cinerariifolium, Chinese gall, flos lonicerae, meconopsis horridula, peach leaf, tea tree essential oil and lemongrass essential oil, has very high killing and repelling effects on mosquitoes, does not have chemical residues and is harmless to the human body.
Owner:廖海湘
Tibetan medicine for treating cardiovascular and cerebrovascular diseases
InactiveCN107773710AImprove crampsPromote hardeningHeavy metal active ingredientsOrganic active ingredientsDiseaseTreatment effect
The invention discloses a Tibetan medicine for treating cardiovascular and cerebrovascular diseases, and belongs to the field of a Tibetan medicine for treating cardiovascular and cerebrovascular diseases. The Tibetan medicine includes 75 medicinal materials comprising herba saussureae cum flore, rose-boots, rhizoma bergeniae, dracocephalum tanguticum maxim, radix inulae racemosae, meconopsis horridula, herba delphinii brunoniani, herba gentianae urnulae, herba corydalis impatiens, radix et rhizoma rubiae, rhizoma acori calami, flos pyrethri tatsienensis, saffron, and aster souliei franch. Theraw materials are prepared into water pills through specific processing technology. Compared with a medicine in the prior art, the Tibetan medicine fully follows the basic principle of comprehensivetreatment of cardiovascular system, blood, myocardial function, and nervous system, overcomes the problem of the single treatment manner of treating one symptom of a western medicine, and can synthetically regulate the functions of three major factors including 'Long', 'Chiba', 'Peigen' of the human body. The Tibetan medicine can integrally regulate blood circulation and blood pressure of the human body, reduces the blood viscosity and lipid, frees the collateral vessels, improves cardiac and cerebral angiospasm and sclerosis and neurological functions, and activates damaged nerve, and has anintegrated treatment effect on cardiovascular and cerebrovascular diseases.
Owner:西藏雄巴拉曲神水藏药有限公司
Traditional Chinese medicine composition for treating qi deficiency caused fluid keeping failure symptom type purpura
InactiveCN104547713AImprove clinical symptomsClinical symptoms improvedHeavy metal active ingredientsAluminium/calcium/magnesium active ingredientsWahlenbergia marginataYin deficiency
The invention discloses a traditional Chinese medicine composition for treating qi deficiency caused fluid keeping failure symptom type purpura. The traditional Chinese medicine composition is characterized by consisting of pterygopleurum neurophyllum, meconopsis horridula, wild clausena lansium, Chinese Starjasmine stems, herba swertiae davidi, chalk, polygala fallax, myriopteron extensum, hyacinth bean flower, tofieldia divergens, ficus comate roots, corallodiscus cordatulus, red halloysite, ginkgo roots, wahlenbergia marginata, hedge glorybind flower roots, satyrium henryi, salvia scapiformis, panax japonicas leaves, eria graminifolia, prickly pear fruit, pennisetum, dryopteris crassirhizoma and liquorice in a certain ratio. The traditional Chinese medicine composition can be used for treating yin deficiency caused fire excess symptom type purpura, and is good in treatment effect and high in curative effect, and the disease does not relapse after being healed.
Owner:柏伟伟
Traditional Chinese medicine for treating nephritis of Schonlein-Henoch purpura and preparation method thereof
InactiveCN104383382ASignificant effectQuick resultsDispersion deliveryUnknown materialsPollenLicorice roots
The invention discloses a traditional Chinese medicine for treating nephritis of Schonlein-Henoch purpura. The traditional Chinese medicine is prepared from the following medicinal materials: lalang grass rhizome, isatis root, trichosanthis, Madder root, alkanet, lophatherum gracile, root of rehmannia, divaricate saposhnikovia root, rheum officinale, pyrola, hawthorns, gypsum, rattletop, rhizoma anemarrhenae, jasmine, panax notoginseng, cat-tail pollen, cicada slough, radix scrophulariae, subprostrate sophora, the root bark of the peony tree, red paeony root, eclipta alba, white paeony root, radix pseudostellariae, merremia sibirica, spiny meconopsis herb, cordyceps sinensis, astragalus, glossy privet fruit, adder tongue herb, rock pine, Oldenlandia diffusa, Gymnocladus chinensis, shinyleaf pricklyash root, patrinia, Tripterygium wilfordii, herba cepbalanoplosis segeti, donkey-hide gelatin, Chinese-dates, motherwort, honeysuckle, dandelion, Chinese violet, rhizoma smilacis glabrae, cortex dictamni, yam rhizome, the root of red-rooted salvia, rhizoma alismatis, radix angelicae and Licorice Roots Northwest Origin. The clinical experiment proves that the traditional Chinese medicine disclosed by the invention can be used for safely and effectively treating nephritis of Schonlein-Henoch purpura.
Owner:鲁翠花
Chinese herbal medicine composition for removing freckles as well as preparation method and application of Chinese herbal medicine composition
InactiveCN104288054ASafe removalEffectively removeCosmetic preparationsToilet preparationsHerb medicineCurative effect
The invention discloses a Chinese herbal medicine composition for removing freckles. The Chinese herbal medicine composition is prepared from the following raw materials in parts by weight: 18-50 parts of dandelion, 15-40 parts of pedicularis davidii, 12-30 parts of conic gymnadenia tuber and 6-20 parts of meconopsis horridula. The invention also discloses a preparation method and application of the Chinese herbal medicine composition. When the Chinese herbal medicine composition disclosed by the invention is used as an active ingredient to be added into cosmetics, a formula system is designed according to different skins, so that a safer and effective freckle removing effect is achieved; in addition, the curative effect is stable, and freckles are not easy to recur.
Owner:CANTON DAMEKISS DAILY CHEM FACTORY LIMITED
Traditional Chinese medicine for treating blood stasis and Qi stagnation caused scapulohumeral periarthritis and preparation method thereof
InactiveCN104225427ADefinite curative effectSmall side effectsSkeletal disorderPlant ingredientsAucuba chinensisSide effect
The invention provides a traditional Chinese medicine for treating blood stasis and Qi stagnation caused scapulohumeral periarthritis and a preparation method thereof. The traditional Chinese medicine comprises the raw medicines of evergreen mucuna root and leaf, hylotelephium verticillatum, meconopsis horridula, aralia undulata, ormosia henryi, aucuba chinensis, salvia evansiana, david anemone, curious kadsura root stem, murraya paniculata, morinda umbellate, mucuna macrocarpa wallich, alpinia japonica, schizophragma integrifolium, greyhair cipadessa root or leaf, litsea rotundifolia, gaultheria, cissus pteroclada hayata and alangium chinense harms. The traditional Chinese medicine shows an extract effect on treating blood stasis and Qi stagnation caused scapulohumeral periarthritis and has small toxic and side effects.
Owner:赵志凤
Pharmaceutical composition, its preparation process and usage
InactiveCN1634159ASimple preparation processThe preparation process is stablePowder deliveryDigestive systemMonkshoodsUse medication
The invention provides a pharmaceutical composition, its preparation process and use, wherein the composition is prepared from pomegranate seed, safflower, long pepper, Cinnamomum cassia, cardamom, by a finite of weight ratio proportion, or from monkshood, Artemisinine, celery, cow-bezoar, potato, saffron, Chinese ephedra, and tabasheer. the composition is effective for treating various hepatitis.
Owner:乡城县藏医院
Traditional Chinese medicinal preparation for treating thromboangiitis obliterans and preparation method of traditional Chinese medicinal preparation
PendingCN105125988ADefinite curative effectLittle side effectsCardiovascular disorderPlant ingredientsMedicinal herbsCaryopteris incana
The invention provides a traditional Chinese medicinal preparation for treating thromboangiitis obliterans and a preparation method of the traditional Chinese medicinal preparation. The traditional Chinese medicinal preparation comprises the following raw medicinal materials of hedychium coronarium koen, asarum caudigerum, bark of fragrant spicebush, caryopteris incana, semen litchi, root of mysorethorn, rhododendron thymifolium maxim, berchemia floribunda brongn, meconopsis horridula, hylotelephium verticillatum, latouchea fokiensis, davallia formosana, salvia evansiana and oxalis acetosella. The traditional Chinese medicinal preparation provided by the invention has a definite therapeutic effect for the thromboangiitis obliterans, and has small side effects.
Owner:孙桂云
Traditional Chinese medicine for treating primary PCI (percutaneous coronary intervention) postoperative poor myocardial perfusion of patients suffering from heart-qi deficiency type ST-segment elevation myocardial infarction
InactiveCN105362372AImprove myocardial perfusionCompatibility is reasonableCardiovascular disorderPlant ingredientsNigella damascenaPercutaneous coronary intervention
The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating primary PCI (percutaneous coronary intervention) postoperative poor myocardial perfusion of patients suffering from heart-qi deficiency type ST-segment elevation myocardial infarction. The traditional Chinese medicine composition which is a traditional Chinese medicine comprises, by weight, 4-8 parts of nigella damascena, 4-8 parts of herba alyxiae sinensis, 4-8 parts of Phlegmariurushamiltonii (Spreng.) LoveetLovevar. petiolatus (Clarke) Ching, 4-8 parts of fructus psoraleae, 4-8 parts of semen ginkgo roots, 2-4 parts of meconopsis horridula, 4-8 parts of radix paeoniae alba, 4-8 parts of buddleja asiatica, 4-8 parts of plumbago indica and 4-8 parts of radix glycyrrhizae. The traditional Chinese medicine composition has the advantages that various medicines are used with one another, and accordingly effects of 'nourishing heart-qi and agitating heart vessels' can be jointly realized; myocardial perfusion of the patients suffering from the primary PCI postoperative poor myocardial perfusion and the STEMI (ST-segment elevation myocardial infarction) can be obviously improved.
Owner:JINAN BANGWEN MEDICAL TECH
Traditional Chinese medicine for treating qi-stagnation and blood-stasis type craniocerebral trauma syndrome and preparation method of traditional Chinese medicine
InactiveCN104740210ADefinite curative effectSmall side effectsNervous disorderPlant ingredientsSide effectCurative effect
The invention provides a traditional Chinese medicine for treating qi-stagnation and blood-stasis type craniocerebral trauma syndrome and a preparation method of the traditional Chinese medicine. The traditional Chinese medicine is prepared from the following raw herbal materials: meconopsis horridula, rauwolfia, fructus tribuli purus, red sage root, ixeris sonchifolia hance, aspidistra elatior, herb or root of common rockvine, zanthoxylum nitidum dc, mysorethorn, style pachysandra herb, ipomoea cairica, heterophyllous wing seedtreeroot and beechey fig root. The traditional Chinese medicine disclosed by the invention is exact in curative effect in treating qi-stagnation and blood-stasis type craniocerebral trauma syndrome, and small in toxic or side effect.
Owner:成磊
Traditional Chinese medicine for treating qi-stagnation and blood stasis lumbar disc herniation and preparation method thereof
InactiveCN103520432BQuick effectDefinite curative effectAntipyreticAnalgesicsMedicinal herbsCentipede
Owner:王帅华
Traditional Chinese medicine for curing viral oesophagitis
InactiveCN106491981ADefinite curative effectNo side effectsAnthropod material medical ingredientsDigestive systemSide effectCraspedolobium
The invention discloses a traditional Chinese medicine for curing viral oesophagitis. The traditional Chinese medicine comprises the Chinese herbal medicines of hongkong rhaphidophora stem, begonia root, fortune chloranthus herb, hemp flower, ciliate desert-grass, mulberry worm, nightshade root, crabshell, melandrium apricum, winter jasmine leaf, elaegnus henryi, paliurus ramosissimus, meconopsis horridula, ciliate leucas, craspedolobium root, lysimachia barystachys bunge, small-leaved photinia, west china hypericum, and brooklet anemone root. The pure natural Chinese herbal medicines are taken as raw materials, both the symptoms and the root causes are treated, the curative effect is obvious, no toxic or side effects are caused, and the viral oesophagitis is difficult to recur.
Owner:吴水清
Traditional Chinese medicine composition for treating weakened body resistance stagnant-heat hepatitis b with hepatic fibrosis
InactiveCN105168726ARelief of clinical symptomsCompatibility is reasonableDigestive systemAntiviralsHepatic fibrosisElaeagnus
The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating weakened body resistance stagnant-heat hepatitis b with hepatic fibrosis. The traditional Chinese medicine composition comprises the following traditional Chinese medicines in parts by weight: 4-8 parts of carex kobomugi ohwi, 5-13 parts of cyananthus incanus Hook. F et Thons., 5-13 parts of aleuritopteris squamosa (Hope et C.H.Wright) ching, 6-14 parts of ficus lyrata, 6-14 parts of radix campanumoeae, 6-14 parts of linaria buriaticaTarcz.etBenth., 6-14 parts of arteimiaisiasieuersianaehrhartexwilld., 4-8 parts of elaeagnus viridis Serv.var. delavayi Lecte., 8-16 parts of brachystemma calycinu D.Don, 6-14 parts of araliaundulatahand.-Mazz, 1-3 parts of meconopsis horridula Hook.f.ex Thoms., and 4-8 parts of liquorice. The traditional Chinese medicines are combined to exert the effect of invigorating spleen and supplementing qi, clearing heat and promoting dieresis, and promoting blood circulation to remove blood stasis, carefully considers the pathogenesis of the weakened body resistance stagnant-heat hepatitis b with hepatic fibrosis, can alleviate clinical symptoms of patients with hepatic fibrosis, can reduce serum AST, ALT and four indicators of hepatic fibrosis, and improves the liver function and hepatic fibrosis degree.
Owner:JINAN BANGWEN MEDICAL TECH
Aerosol for quickly killing cockroaches
InactiveCN106212547ALong-lasting killing effectMaintain killing effectBiocideDisinfectantsVillosaAdditive ingredient
The invention provides an aerosol for quickly killing cockroaches. The aerosol for quickly killing the cockroaches is prepared from 11 plant components, namely gonatanthus pumilus, rhododendron cinnabarinum, lyonia villosa, astragalus strictus, herb of spiny meconopsis, semen hyoscyami, root of anemone demissa, herb of siberian cocklebur, root and seed of anisodus luridus, honeysuckle flower and herba menthae. Multiple effective ingredients such as volatile oil and alkaloid contained in medicinal materials and polyvidone can generate a synergism effect; the aerosol can be directly used for killing insects in a room and an airtight environment in a spraying form, can slowly release the effective ingredients for killing the insects and sustainably keeps a killing effect on the cockroaches.
Owner:GUANGDONG KONBOM SCI & TECH IND CO LTD
Traditional Chinese medicine composition for treating poor heart muscle perfusion after direct PCI surgery of heart-yang inactivation type ST-elevated myocardial infarction
InactiveCN105381164AImprove myocardial perfusionCompatibility is reasonableDispersion deliveryPteridophyta/filicophyta medical ingredientsGLYCYRRHIZA EXTRACTPerfusion
The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating poor heart muscle perfusion after a direct PCI surgery of heart-yang inactivation type ST-elevated myocardial infarction (STEMI). The traditional Chinese medicine composition is prepared from the following traditional Chinese medicines in parts by weight: 5 to 13 parts of arisaema fargesii buchet, 4 to 8 parts of herba alyxiae sinensis, 4 to 8 parts of phlegmariurus hamiltonii, 4 to 8 parts of psoralea corylifolia, 4 to 8 parts of ginkgo biloba, 2 to 4 parts of meconopsis horridula, 4 to 8 parts of debark peony root, 4 to 8 parts of buddleja asiatica, 4 to 8 parts of plumbago indica and 4 to 8 parts of liquorice root. Various medicines are jointly used to achieve the efficacy of tonifying yang and activating heart-yang. The poor heart muscle perfusion of a patient after the direct PCI surgery of STEMI can be obviously improved.
Owner:JINAN BANGWEN MEDICAL TECH
A traditional Chinese medicine for treating qi stagnation and blood stasis type craniocerebral trauma syndrome and its preparation method
InactiveCN104740210BDefinite curative effectSmall side effectsNervous disorderPlant ingredientsIpomoea cairicaSide effect
Owner:成磊
Traditional Chinese medicine composition for treating knee joint meniscus injuries
InactiveCN104940463ASignificant effect on injuryImprove efficiencyAntipyreticAnalgesicsSide effectKnee Joint
The invention relates to a traditional Chinese medicine composition for treating knee joint meniscus injuries. The traditional Chinese medicine composition is composed of the following traditional Chinese medicine raw materials by weight: 5-8g of siberian walking fern, 3-5g of common achyranthes herb, 5-7g of meconopsis horridula, 3-8g of lycopodium obscurum, 5-10g of herba aristolochiae, 3-5g of piper hancei, 3-8g of nauclea officinalis, 5-8g of flaccid knotweed herb, 2-4g of obcordateleaf raspberry root, 2-5g of solanum torvum, 3-8g of petasites japonicus, 3-10g of Japanese farfugium herb, 5-10g of rhizoma nelumbinis, 3-5g of cryptolepis dubia, 2-5g of ventilago leiocarpa benth, 3-8g of acanthopanax obovatus hoo, 2-8g of largeleaf curculigo rhizome and 3-5g of elsholtxin fruticosa rehd. The traditional Chinese medicine composition disclosed by the invention has the effects of promoting blood circulation and removing blood stasis, relieving swelling and pain, nourishing blood and promoting blood circulation, relaxing tendons and activating collaterals, and tonifying kidney and strengthening tendons, as well as is remarkable in curative effect on knee joint meniscus injuries, high in effective rate, not liable to recur, and free from toxic and side effects.
Owner:高晓菡
Pharmaceutical composition, its preparation process and usage
InactiveCN100528218CHas heat-clearing and anti-inflammatory propertiesImprove liver functionPowder deliveryDigestive systemUse medicationHepatitis
The invention provides a pharmaceutical composition and its preparation method and application. Specifically, it is a combination made of pomegranate seeds, safflower, longan longan, cinnamon, Meconopsis prickly, and white cardamom according to a certain weight ratio. Combined use of compound I and composition II made of aconitum, meconopsis, swertia, bezoar, cabbage indigo, aristolochia, saffron, ephedra, and Tianzhuhuang in a certain weight ratio for the treatment of hepatitis The two pharmaceutical compositions of the present invention, the prescriptions of the two pharmaceutical compositions used in combination with the pharmaceutical composition of the present invention are scientific and reasonable, through the joint use of the two pharmaceutical compositions, the onset of effect is fast, and it is effective for various hepatitis. The pharmaceutical composition of the present invention It is safe, effective, and convenient to store, and provides a new medication option for clinical practice.
Owner:乡城县藏医院
Traditional Chinese medicine external application agent for treating bone fracture and nursing method
The invention discloses a traditional Chinese medicine external application agent for treating bone fracture, and belongs to the technical field of traditional Chinese medicine. Aiming at pathogenesis causing the bone fracture and according to a traditional Chinese medicine theory based on syndrome differentiation and treatment, the traditional Chinese medicine external application agent is prepared from the following traditional Chinese medicine of sixangular dysosma rhizome, meconopsis horridula, arabis pendula, vesper iris herb, polygonum runcinatum, small bugbane rhizome, streblus indicus, root and bark of podocarpus macrophyllus, herba et radix spiraeae salicifoliae, callicarpa rubella, elaegnus henryi, root of womwoodleaf ampelocissus, euphorbia humifusa and root and bark of lindenleaf torricellia which are selected by an inventor and have the functions of promoting circulation of qi and blood, relieving pain, diminishing swelling, setting a bone, promoting granulation, diminishing inflammation and detoxifying; through a clinical test, the total effective rate is up to 100 percent.
Owner:刘金枝
Crayfish feed with ultrahigh immune effect
InactiveCN112056471AImprove immunityReduce mortalityClimate change adaptationAnimal feeding stuffBiotechnologyAnimal science
The invention discloses a crayfish feed with an ultrahigh immune effect. The crayfish feed comprises the following components of alfalfa, selenium-enriched barley, phytase, eggs, soybean meal, vegetable leaves, edible salt and a traditional Chinese medicine additive, wherein the traditional Chinese medicine additive is prepared from the following components of flos chrysanthemi, herba taraxaci, radix glycyrrhizae, radix astragali seu hedysari, flos lonicerae and meconopsis horridula. Meconopsis horridula has the functions of clearing heat, relieving pain, setting bones and promoting blood circulation to remove blood stasis, and is generally used for treating surgical injuries. The immunity of the crayfish can be remarkably improved and the death rate of the crayfish can be reduced by onlyadding a small amount of meconopsis horridula.
Owner:史建平
Traditional Chinese medicine composition for treating persistent prosopalgia entering collaterals
InactiveCN104606431ASafe and effective treatmentImprove clinical symptomsNervous disorderPlant ingredientsMedicinal herbsNeocinnamomum delavayi
The invention discloses a traditional Chinese medicine composition for treating persistent prosopalgia entering collaterals. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 6-9 parts of three-leaf hydrocotyle verticillata, 10-15 parts of madder, 9-12 parts of kirilow rhodiola rhizome and root, 9-12 parts of salvia evansiana, 1-3 parts of meconopsis horridula, 9-12 parts of aralia undulate, 9-12 parts of arachnoid cyanotis root, 12-15 parts of dobineae, 15-20 parts of blumea lanceolaria, 3-6 parts of chamaesium spatuliferum, 25-30 parts of snow of june herb, 15-20 parts of wrightia pubescens, 15-20 parts of cyperaceae scleria terrestris, 4-8 parts of drumstick tree fruit, 10-15 parts of neocinnamomum delavayi and 4-8 parts of liquorice. The traditional Chinese medicine composition can be used for treating persistent prosopalgia entering collaterals and is high in effective rate, reliable in curative effect and free of reoccurrence after healing.
Owner:胡运冲
Medicine composition for treating chronic active hepatitis and preparation method of medicine composition
The invention discloses medicine composition for treating chronic active hepatitis and a preparation method of the medicine composition. The medicine composition for treating chronic active hepatitis comprises ingredients as follows: wild parsley, osbeckia crinita, Rubus saxatilis L., Eurya hebeclados Ling, scolopendra, Chinese brake herb, field sowthistle herb, clematis roots, roots of champion pentasacme, Chinese wedelia herb, flabelate maiden-hair herb, roots of spine aralia, Meconopsis horridula Hook. f. et Thoms. var. racemosa (Maxim.) Prain., swertia punicea, all-grass of maidenhair, sida mysorensis, Iris tectorum Maxim., boor's mustard herb, abrus precatorius leaf extracts, Salvia prionitis Hance extracts and wallich eriophyton nano powder. Traditional Chinese medicines are reasonably selected according to clinical experience for elaborate preparation of the medicine composition; the medicine composition has the efficacy of liver soothing, spleen invigorating, detoxification, liver protection, liver calming for yang suppressing, heat clearing, diuresis, kidney tonification for yang strengthening, regulation of middle-warmer energy and qi tonification, can effectively repair injured cells of the liver, promote recovery of a cell regeneration function, has a remarkable treatment effect on chronic active hepatitis, is safe and does not have side effects, and the medicine property is mild.
Owner:张龙跃
Skin care product containing plant extract, composition and preparation method and application of skin care product
PendingCN114344213ALessen composureAvoid damageCosmetic preparationsToilet preparationsBiotechnologyRhizome
The invention discloses a natural plant skin care product with whitening, spot fading, radiation resisting and light aging effects, a composition and a preparation method and application of the natural plant skin care product. The composition is prepared from the following components in parts by mass: 1 to 30 parts of meconopsis horridis ethanol extract, 1 to 30 parts of rheum tanguticum leaf extract, 1 to 30 parts of rheum tanguticum rhizome ethanol extract and 1 to 30 parts of arbutin. The skin care composition provided by the invention can effectively reduce melanin pigmentation, prevent ultraviolet damage and improve skin resistance, and the skin care composition is obvious and lasting in effect, free of toxic and side effects and high in safety.
Owner:青海省中医院 +2
Pharmaceutical composition for thyroid cancer postoperative iodine 131 radiotherapy
InactiveCN105853612ARaise the Karnofsky scoreImprove autoimmunityImmunological disordersAntineoplastic agentsSide effectToxic material
The invention belongs to the field of traditional Chinese medicine and particularly relates to a pharmaceutical composition for thyroid cancer postoperative iodine 131 radiotherapy and a preparation method thereof. The pharmaceutical composition is prepared from viola japonica, bauhinia seeds, meconopsis horridula, snake grape roots, wild buckwheat stems and leaves, milkvetch roots, panax pseudo-ginseng Wsll. Var, fructus lycii, beechey fig roots and Chinese dates in a refining mode. All the medicinal materials are combined and are in precise compatibility, and the effects of promoting blood circulation to remove blood stasis, clearing away heat and toxic materials, removing stasis and subsiding swelling, strengthening the body resistance and tonifying deficiency, driving away evils and removing toxins and the like are achieved. Body resistance strengthening is achieved while evils are eliminated, the organism immunity is improved, and the effects of relieving traditional Chinese medicine clinical symptoms and relieving side effects of radiotherapy are achieved.
Owner:QINGDAO CHENDA BIOLOGICAL SCI & TECH
Traditional Chinese medicine composition for treating phlegm-blood stasis syndrome type hyperthyreosis with automatic junctional tachycardia
InactiveCN105688161AReturn to functional levelCompatibility is reasonableDispersion deliveryEndocrine system disorderLicorice rootsAdemetionine
The invention belongs to the technical field of medicine, and particularly relates to a traditional Chinese medicine composition for treating phlegm-blood stasis syndrome type hyperthyreosis with automatic junctional tachycardia. The traditional Chinese medicine composition is prepared from, by weight, 4-8 parts of herb of spiny meconopsis, 4-8 parts of bauhinia seeds, 4-8 parts of common dysosmatis rhizomes and roots, 4-8 parts of roots of cissus repens, 4-8 parts of herb of sarcococca hookeriana Baill., 4-8 parts of roots of Chinese pulsatilla, 4-8 parts of all-grass of winkled marshweed, 4-8 parts of herb of rhynchoglossum obliquum Bl., 4-8 parts of herb of goodyera schlechtendaliana Reichb.f., 4-8 parts of fruit of celastrus flagellaris Rupr., 4-8 parts of herb of ziziphora clinopodioides Lam. and 4-8 parts of licorice roots. All the medicine materials are cooperatively used to jointly achieve the effects of promoting qi circulation, resolving depression, activating blood circulation, dissipating phlegm, softening hardness to dissipate stagnation, calming the mind and soothing the nerves. The average heart rate can be lowered, the thyroid function level can be recovered, no influence is generated on the safety indexes, and the safety is good.
Owner:JINAN BANGWEN MEDICAL TECH
Traditional Chinese medicine composition for treating poor heart muscle perfusion after direct PCI surgery of blood stasis stagnation type ST-elevated myocardial infarction
InactiveCN105381008AImprove myocardial perfusionCompatibility is reasonableCardiovascular disorderPlant ingredientsVeinCardiac muscle
The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating poor heart muscle perfusion after a direct PCI surgery of blood stasis stagnation type ST-elevated myocardial infarction (STEMI). The traditional Chinese medicine composition consists of the following traditional Chinese medicines in parts by weight: 4 to 8 parts of Aralia undulata, 2 to 4 parts of Meconopsis horridula, 4 to 8 parts of debark peony root, 4 to 8 parts of Buddleja asiatica, 4 to 8 parts of Plumbago indica and 4 to 8 parts of liquorice root. Various medicines are jointly used to achieve the efficacies of promoting blood circulation, removing stasis, dredging veins and alleviating pains. The poor heart muscle perfusion of a patient after the direct PCI surgery of STEMI can be obviously improved.
Owner:JINAN BANGWEN MEDICAL TECH
Traditional Chinese medicine composition for treating blood stasis channel blocking type cerebral embolism and preparation method of composition
InactiveCN104258221APrevent pathological aggregationImprove the quality of lifeAnthropod material medical ingredientsDispersion deliveryCentipedeRed yeast rice
The invention discloses a traditional Chinese medicine composition for treating blood stasis channel blocking type cerebral embolism and a preparation method of the composition. The traditional Chinese medicine composition comprises the following raw materials: prepared rehmannia root, longan pulp, fructus broussonetiae, tuber fleeceflower stem, mother of pearl, tribulus terrestris, uncaria rhynchophylla, earthworm, centipedes, corydalis amabilis, caulis spatholobi, campsis grandiflora, rhizoma typhonii, rice sprouts, paederia foetida, radix clematidis, zaocys dhumnade, lycopodium clavatum, erycibe obtusifolia, fructus liquidambaris, achyranthes aspera, helwingia root, dysosma versipellis, begonia root, sea crabs, rhizoma sparganii, herba lycopi, evergreen mucuna root and leaf, red yeast rice, meconopsis horridula, huechys sanguinea, moutan bark, ormosia henryi, aralia undulata, colysis bonii, medical stone, scytosiphon lomentarius, helwingia himalaica, clematis chrysocoma, iris seeds, uniflower swisscentaury root, jumping spider and comely indigo. The traditional Chinese medicine composition has the effects of activating blood to remove stasis and unblocking channels, is mainly used for treating the blood stasis channel blocking type cerebral embolism, and has the advantages of treatment based on syndrome differentiation, strong pertinence, capability of controlling the disease condition in time, remarkable treatment effect, safety, effectiveness, simple preparation process, convenience in administration, low price and easiness for acceptance by patients.
Owner:乔世琴
Botanical insecticide
InactiveCN106386890ALong-lasting killing effectMaintain killing effectBiocideDisinfectantsMedicinal herbsPieris formosa
The invention provides a botanical insecticide; the botanical insecticide is composed of 11 plant components: aconitum kongboense, cotoneaster microphyllus, pieris formosa, astragalus strictus, meconopsis horridula, semen hyoscyami, przewalskia tangutica maxim., podophyllum hexandrum, anisodus luridus, borneol and mint; volatile oils, alkaloids and various effective ingredients contained in the medicinal materials can produce synergistic effect with povidone, and the insecticide can be directly used for killing insects indoor and in closed environments in an atomizing form, can slowly release effective ingredients for killing the insects, and keeps the killing effect on cockroaches lastingly.
Owner:GUANGDONG KONBOM SCI & TECH IND CO LTD
Pharmaceutical composition for treating traumatic injury
The invention provides a pharmaceutical composition for treating traumatic injury. The pharmaceutical composition is composed of 110 parts of ash bark, 40 to 80 parts of west Sichuan pyrethrum, 20 to 40 parts of pseudo-ginseng, 40 to 80 parts of Meconopsis horridula and 2 to 4 parts of borneol. Clinical practice proves that the pharmaceutical composition has obvious advantages in treatment of traumatic injury; and compared with a reference substance, i.e., an ash bark bone-setting capsule, the pharmaceutical composition provided by the invention has substantial effect on alleviation of pain and removal of ecchymoses.
Owner:SHANDONG JINHE DRUG RES DEV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com